Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
LEGN
Legend Biotech Corp
NASDAQ · Pharmaceutical Preparations
Last close
$19.89
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
RECENT INSIDER TRADES
2026-10-01
· Sanders Corazon (Corsee) D.
(Director)
· SELL
2026-09-28
· Heyman Tomas J.
(Director)
· OTHER
2026-09-28
· Mao Li
(Director)
· OTHER
2026-09-28
· Casey Patrick John
(Director)
· OTHER
2026-09-28
· Salovey Peter
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
233
Shares held
110,381,214
Value
$3.27B
Percent of shares outstanding
29.84%
As of quarter end
2026-06-30
RECENT NEWS
Legend Biotech Launches Inaugural ELITE Grant Program to Advance the Next Generation of CAR-T Innovation in Multiple Myeloma
H.C. Wainwright reiterates Legend Biotech stock rating on durability data
Legend Biotech reports 5-year CARVYKTI data in myeloma patients
Legend Biotech reports 69.2% five-year survival rate for CARVYKTI
Legend Biotech appoints new CEO
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Legend Biotech Corp (LEGN) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit